Teladoc Health Sees Unusually High Options Volume (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) was the recipient of some unusual options trading on Monday. Stock traders purchased 33,776 call options on the company. This is an increase of approximately 105% compared to the average volume of 16,460 call options.

Insider Buying and Selling at Teladoc Health

In other news, insider Carlos Nueno sold 3,958 shares of Teladoc Health stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total transaction of $27,151.88. Following the sale, the insider now owns 17,645 shares of the company's stock, valued at approximately $121,044.70. This trade represents a 18.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Fernando M. Rodrigues sold 4,174 shares of Teladoc Health stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total value of $28,842.34. The disclosure for this sale can be found here. Insiders have sold 18,656 shares of company stock valued at $128,189 in the last 90 days. 0.58% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in TDOC. Whipplewood Advisors LLC bought a new stake in shares of Teladoc Health in the fourth quarter worth about $29,000. Golden State Wealth Management LLC grew its stake in Teladoc Health by 102.6% in the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after purchasing an additional 1,690 shares in the last quarter. National Bank of Canada FI grew its stake in Teladoc Health by 79.4% in the first quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock valued at $28,000 after purchasing an additional 1,581 shares in the last quarter. Lindbrook Capital LLC lifted its position in shares of Teladoc Health by 78.9% in the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after buying an additional 1,612 shares during the last quarter. Finally, SVB Wealth LLC acquired a new stake in shares of Teladoc Health in the first quarter valued at approximately $37,000. Institutional investors own 76.82% of the company's stock.

Teladoc Health Trading Up 5.9%

Shares of TDOC traded up $0.45 during trading hours on Thursday, hitting $8.02. 9,460,642 shares of the stock traded hands, compared to its average volume of 6,396,803. The company has a current ratio of 1.68, a quick ratio of 1.64 and a debt-to-equity ratio of 0.70. Teladoc Health has a 1-year low of $6.35 and a 1-year high of $15.21. The firm has a market capitalization of $1.41 billion, a PE ratio of -1.35 and a beta of 1.78. The business has a fifty day moving average of $7.16 and a 200-day moving average of $8.78.

Wall Street Analysts Forecast Growth

Several analysts recently commented on TDOC shares. Truist Financial decreased their price target on Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a research note on Tuesday, May 27th. Bank of America cut their price objective on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research report on Wednesday, May 28th. Wells Fargo & Company cut their price objective on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a research report on Thursday, May 8th. Canaccord Genuity Group cut their price objective on Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a research report on Thursday, May 1st. Finally, Citigroup cut their price objective on Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research report on Friday, April 25th. Twelve analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, Teladoc Health currently has a consensus rating of "Hold" and a consensus target price of $9.60.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.